Filing Details
- Accession Number:
- 0000899243-21-009505
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-03-03 18:46:27
- Reporting Period:
- 2021-03-01
- Accepted Time:
- 2021-03-03 18:46:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1466301 | Clovis Oncology Inc. | CLVS | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1283569 | W Daniel Muehl | C/O Clovis Oncology, Inc. 5500 Flatiron Parkway, Suite 100 Boulder CO 80301 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-03-02 | 469 | $0.00 | 47,459 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-03-01 | 207 | $6.29 | 47,252 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-03-02 | 563 | $0.00 | 47,815 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-03-01 | 249 | $6.29 | 47,566 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Units | Acquisiton | 2021-03-01 | 81,000 | $0.00 | 81,000 | $0.00 |
| Common Stock | Restricted Stock Units | Acquisiton | 2021-03-01 | 469 | $0.00 | 469 | $0.00 |
| Common Stock | Restricted Stock Units | Acquisiton | 2021-03-01 | 563 | $0.00 | 563 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 81,000 | No | 4 | A | Direct | ||
| 0 | No | 4 | M | Direct | ||
| 2,250 | No | 4 | M | Direct |
Footnotes
- Each Restricted Stock Unit represents the right to receive one share of Common Stock.
- Represents the shares automatically sold by the reporting person pursuant to an election to satisfy tax withholding obligations in connection with the vesting of the Restricted Stock Units listed in Table II. This sale does not represent a discretionary trade by the reporting person.
- The Restricted Stock Units shall vest as to 25% of the units on March 1, 2022, and the remainder shall vest in substantially equal installments over the 12 quarters immediately following such date.
- On March 27, 2017, the reporting person was granted 7,500 Restricted Stock Units. 25% of such Restricted Stock Units vested on March 1, 2018, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date.
- On March 1, 2018, the reporting person was granted 9,000 Restricted Stock Units. 25% of such Restricted Stock Units vested on March 1, 2019, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date.
Billionaire Hedge Funds
